A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
Status:
RECRUITING
Trial end date:
2027-10-30
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn if BGB-B455 can treat advanced or metastatic solid tumors expressing claudin 6 (CLDN6), a protein that is found on some tumors.
The main questions it aims to answer are:
* What is the recommended dosing for BGB-B455?
* What medical problems do participants have when taking BGB-B455?
The study has two parts:
* Phase 1a: dose escalation and safety expansion
* Phase 1b: dose expansion